Biotechnology Self-Testing Kit Regulation In Russia.
1. Introduction
Biotechnology self-testing kit regulation in Russia concerns the legal control of diagnostic products that enable individuals to examine their own biological samples without the direct assistance of medical professionals.
These products are commonly known as self-testing or in-vitro diagnostic (IVD) medical devices.
Examples include:
Home pregnancy testing kits.
Blood glucose monitoring kits.
HIV self-testing kits.
COVID-19 rapid antigen testing kits.
Home cholesterol testing kits.
Genetic testing and DNA screening kits.
Urine-based diagnostic testing kits.
Fertility and ovulation testing kits.
Russian law regulates these products through medical-device registration, quality and safety requirements, labelling rules, consumer protection, and state supervision.
The central regulatory objective is to ensure that a person using a diagnostic kit independently receives reliable results and is not exposed to unnecessary medical risks.
The principal regulatory authority is the Federal Service for Surveillance in Healthcare (Roszdravnadzor).
An important distinction is that Russia does not have one separate comprehensive statute exclusively governing self-testing kits. Instead, their regulation arises from the broader legal framework governing medical devices and in-vitro diagnostics.
2. Legal Framework Governing Self-Testing Kits in Russia
The principal legislation includes the following:
| Legislation | Regulatory importance |
|---|---|
| Federal Law No. 323-FZ of 21 November 2011 | General regulation of medical devices and healthcare |
| Government Resolution No. 1416 of 27 December 2012 | State registration of medical devices under the Russian national framework |
| EAEU Council Decision No. 46 of 12 February 2016 | Registration and examination of medical devices within the Eurasian Economic Union |
| Federal Law No. 2300-1 of 7 February 1992 | Consumer protection |
| Federal Law No. 152-FZ of 27 July 2006 | Personal data protection |
| Federal Law No. 162-FZ of 29 June 2015 | Standardisation framework |
| GOST R ISO 18113-1-2024 | General IVD labelling and information requirements |
| GOST R ISO 18113-5-2024 | Labelling of IVD equipment intended for self-testing |
The most important provision is Article 38 of Federal Law No. 323-FZ.
Article 38 regulates medical-device circulation, including:
Manufacture and importation.
State registration.
Quality and safety assessment.
Storage and transportation.
Distribution and sale.
Medical application.
Maintenance and disposal.
Under Article 38(4), medical devices generally must be registered before being placed into circulation in Russia.
Consultant Plus+1
3. Definition and Legal Classification of Self-Testing Kits
A self-testing kit is a diagnostic medical device designed to allow a non-professional user to collect a biological sample, perform a diagnostic procedure and, where intended, interpret the result independently.
The Russian national standard GOST R ISO 18113-1-2024 recognises self-testing as the use of a medical device or IVD medical device by a non-professional user who is responsible for collecting data or obtaining the primary sample.
The standard also recognises that self-testing may include independent interpretation of results.
This is important because a product intended for use by a trained laboratory specialist may require different instructions and safety measures from a product intended for an ordinary consumer.
ГАРАНТ+1
Examples of legal classification
| Product | Regulatory character |
|---|---|
| Home pregnancy test | IVD medical device |
| Home blood glucose kit | IVD medical device |
| HIV self-test | IVD medical device |
| Genetic disease screening kit | Potentially an IVD medical device |
| General wellness questionnaire | Not necessarily a medical device |
| Laboratory research reagent | Not necessarily a medical device |
The manufacturer's intended purpose is central to determining whether a product falls within the medical-device regime.
The Eurasian Economic Commission's classification guidance expressly recognises genetic tests designed to diagnose genetic disorders, diseases and predispositions as potential IVD medical devices.
eec.eaeunion.org+1
4. Registration Requirements for Self-Testing Kits
Core regulatory requirement
Manufacturers and authorised representatives must ensure that their products satisfy the applicable registration requirements before commercial circulation.
The Russian national registration system is administered by Roszdravnadzor.
The registration process generally involves the following stages.
Stage 1: Product identification
The manufacturer must establish:
The intended medical purpose.
The biological sample being examined.
The analyte being detected.
The intended user.
The method of testing.
The proposed interpretation of results.
For example, a pregnancy kit designed to detect human chorionic gonadotropin (hCG) in urine must clearly specify its intended diagnostic purpose.
Stage 2: Risk classification
The regulatory classification determines the assessment requirements.
Under the EAEU framework, medical devices are classified into four principal risk classes:
Class 1: Low risk.
Class 2a: Medium risk.
Class 2b: Increased risk.
Class 3: High risk.
IVD devices intended for self-testing by non-professional users are generally classified under the increased-risk provisions of the EAEU IVD classification system.
However, the applicable classification must be determined by the product's intended purpose and the relevant classification rules, rather than simply by its commercial description.
docs.eaeunion.org+1
Stage 3: Technical testing
Testing examines whether the device operates according to its technical specifications.
Relevant considerations include:
Analytical sensitivity.
Analytical specificity.
Accuracy.
Repeatability.
Reproducibility.
Stability.
Reliability of the testing mechanism.
Stage 4: Clinical performance assessment
The manufacturer must provide appropriate evidence that the device performs reliably for its intended diagnostic purpose.
For self-testing products, this includes considering whether ordinary users can correctly collect samples, perform the test and interpret the result.
Stage 5: Registration and market circulation
After the required examination and registration procedure, the appropriate registration documentation must be obtained.
Russia operates both a national registration framework and an EAEU registration framework. EAEU registration is governed by Council Decision No. 46 of 2016.
roszdravnadzor.gov.ru+2
5. Labelling and Instructions for Home Testing
Labelling is particularly important because self-testing kits are intended for use outside professional laboratory environments.
Russia adopted GOST R ISO 18113-5-2024, concerning manufacturer information and labelling for IVD equipment intended for self-testing.
It entered into force on 1 January 2025.
The standard addresses:
Identification of the diagnostic equipment.
Manufacturer information.
Intended use.
Storage conditions.
Warnings and precautions.
Operating procedures.
Testing methods.
Interpretation of results.
Limitations of the test.
Troubleshooting.
Disposal procedures.
Follow-up actions.
Meganorm+1
Example: HIV self-testing kit
The instructions should explain:
How to collect the sample.
How to perform the test.
How long to wait before reading the result.
What constitutes a reactive or non-reactive result.
Why a reactive result requires appropriate confirmatory testing.
Where the user can obtain medical advice.
A manufacturer must not create the impression that a preliminary self-test result is necessarily equivalent to a definitive clinical diagnosis.
6. Regulation of Different Categories of Self-Testing Kits
A. Pregnancy testing kits
Pregnancy kits detect hCG in urine.
The manufacturer must establish the diagnostic performance of the product and provide adequate instructions.
Misleading claims concerning accuracy, early detection or guaranteed results may create liability under consumer-protection law.
B. Blood glucose testing kits
Glucose meters and associated testing strips require particular attention because incorrect readings can influence medical decisions.
The manufacturer must establish the performance of the complete testing system, including compatibility between the meter and its test strips.
A device registered for blood-pressure measurement cannot automatically be marketed as a glucose-measuring device.
C. HIV self-testing kits
HIV self-testing products require careful consideration of diagnostic accuracy, user instructions, confirmatory testing and confidentiality.
A reactive self-test should not be represented as an independently conclusive HIV diagnosis.
D. Genetic self-testing kits
Genetic testing creates additional legal concerns because genetic information may reveal inherited disease risks, biological relationships and other personal information.
Where the product is intended to provide medical diagnostic information, the IVD medical-device requirements may apply.
The processing and transfer of identifiable genetic information must also be examined under Russian personal-data legislation, particularly Federal Law No. 152-FZ.
E. Fertility and ovulation kits
These products may detect hormonal indicators associated with ovulation or fertility.
Their marketing claims must correspond to the intended purpose and demonstrated performance of the device.
A fertility indicator should not automatically be presented as a guarantee of conception or infertility.
7. Consumer Protection and Manufacturer Liability
Federal Law No. 2300-1 on Consumer Protection is relevant to the sale of self-testing kits.
Consumers are entitled to appropriate and reliable information about products.
Manufacturers, importers and sellers may face legal consequences for:
Defective diagnostic products.
Misleading advertising.
Incorrect instructions.
Undisclosed product limitations.
False accuracy claims.
Failure to provide appropriate safety information.
Civil liability may arise under the Russian Civil Code, including provisions concerning compensation for damage caused by defective goods.
For example, if a defective glucose testing kit produces dangerously inaccurate readings and causes injury, the injured person may seek compensation where the applicable legal requirements are satisfied.
8. Personal Data and Genetic Privacy
Self-testing kits increasingly connect to mobile applications and digital platforms.
Some products automatically transmit diagnostic results to manufacturers or external laboratories.
This creates additional regulatory responsibilities.
Under Federal Law No. 152-FZ:
Personal data processing must have a lawful basis.
Appropriate security measures must be implemented.
The purpose of data collection must be defined.
Unauthorised disclosure must be prevented.
Special-category personal data requires additional legal consideration.
Genetic information can create particularly serious privacy concerns because it may reveal information about biological relatives as well as the individual being tested.
A manufacturer cannot assume that purchasing a self-testing kit automatically authorises every subsequent use of the consumer's genetic information.
9. Important Russian Judicial Decisions and Case Laws
There is an important limitation in Russian case law: reported decisions specifically concerning consumer-operated home diagnostic kits are relatively limited. However, Russian courts have decided cases concerning unregistered diagnostic devices, incorrect registration claims and medical-device conformity. These decisions provide relevant principles for self-testing regulation.
Case 1: Medical Diagnostic Systems LLC v. Roszdravnadzor
Arbitrazh Court of St Petersburg and Leningrad Region, 7 April 2020, Case No. A56-11126/2020
sudact.ru
Facts:
Roszdravnadzor investigated the distribution of a device called Omelon B-2, marketed as a non-invasive glucose meter and blood-pressure monitor.
The device had documentation relating to an automatic blood-pressure monitor, but the registration certificate did not establish approval for its additional claimed glucose-measuring function.
The company had supplied the device under a government contract.
Legal issue:
Whether a medical device could be distributed for an additional diagnostic purpose when that purpose was not covered by its existing registration.
Court's approach:
The court examined the registration certificate, technical documentation and manufacturer's declared intended purpose.
The regulatory authority argued that the glucose-measuring function had not undergone the required assessment and that the device was therefore being circulated without appropriate registration.
Legal principle:
Registration for one medical purpose does not automatically authorise additional diagnostic functions.
Relevance to self-testing kits:
A manufacturer cannot register a home blood-pressure monitor and subsequently advertise it as a glucose-testing device without satisfying the applicable regulatory requirements.
This decision is particularly important for multifunctional home diagnostic devices.
Case 2: Biosvyaz LLC v. Samara Pharmacy Institution
Arbitrazh Court of the Volga-Vyatka District, Case No. A55-7541/2024, judgment dated 11 June 2025
sudact.ru+1
Facts:
The dispute concerned a public procurement contract for medical equipment.
The supplier sought payment of approximately 2.6 million roubles for equipment supplied to medical institutions.
The dispute involved questions concerning conformity with the registered medical-device documentation and the acceptability of the supplied equipment.
Legal issue:
Whether equipment supplied under a medical-device contract could be treated as compliant when questions arose concerning its identity, registration documentation and conformity.
Court's approach:
The appellate court rejected the supplier's payment claim, and the district court dismissed the supplier's cassation appeal.
The courts considered the registration documentation and the evidence concerning the supplied equipment.
Legal principle:
A medical-device supplier must establish that the actual product supplied corresponds to the legally registered product and the contractual specifications.
Relevance to self-testing kits:
A supplier cannot rely merely on a registration certificate for a similar diagnostic product. The actual testing kit, its components and its approved intended purpose must correspond to the registration documentation.
Case 3: Arbitrazh Court of the Volga-Vyatka District – Case No. A29-2292/2025
Judgment dated 23 January 2026, No. F01-4428/25
ГАРАНТ
Facts:
The dispute concerned the circulation of medical equipment that did not correspond to the registered product.
The responsible organisation challenged its administrative liability.
Legal issue:
Whether a distributor could avoid responsibility by arguing that the discrepancy resulted from the actions of third parties or that the packaging had been opened.
Court's approach:
The court maintained that the supplied equipment did not correspond to the registered medical device.
It emphasised that organisations involved in medical-device circulation must exercise due diligence and verify regulatory conformity.
Legal principle:
A distributor's responsibility is not automatically avoided merely because another party contributed to the discrepancy.
Relevance to self-testing kits:
Importers and distributors of pregnancy, glucose, HIV and genetic testing kits should verify the registration status and product identity before placing products on the Russian market.
This is particularly important where imported kits are sold through online marketplaces.
10. Administrative and Criminal Liability
The Russian regulatory framework provides several enforcement mechanisms.
A. Administrative liability
The Code of Administrative Offences of the Russian Federation contains provisions applicable to violations involving medical-device circulation.
Article 6.33 is particularly important in cases involving the circulation of falsified, substandard or unregistered medical products, subject to the specific statutory elements.
Potential enforcement consequences include:
Administrative fines.
Confiscation where legally authorised.
Restrictions on distribution.
Suspension or withdrawal of products.
Other applicable administrative measures.
The 2020 Omelon B-2 case demonstrates the relevance of Article 6.33 to unregistered medical-device circulation.
sudact.ru
B. Criminal liability
Depending on the facts, serious misconduct may also engage provisions of the Russian Criminal Code.
Potentially relevant provisions include:
Article 238: Production, storage, transportation or sale of goods and products that do not meet safety requirements, where its statutory elements are established.
Article 238.1: Circulation of falsified, substandard or unregistered medicinal products and medical devices in circumstances covered by that provision.
Article 238.2: Certain violations involving the circulation of medical devices, where the applicable statutory requirements are met.
Criminal liability is not automatic merely because a self-testing kit has a registration defect. The particular offence, conduct, consequences and other statutory elements must be established.
11. Regulation of Online Sales and Imported Self-Testing Kits
Online distribution has created additional enforcement challenges.
A foreign manufacturer wishing to introduce self-testing kits into Russia must consider:
Applicable Russian or EAEU registration.
Manufacturer and authorised representative documentation.
Customs and import requirements.
Russian-language product information.
Correct product classification.
Compliance with advertising requirements.
Personal-data processing obligations.
An online seller cannot avoid medical-device regulation simply by describing a diagnostic kit as a consumer wellness product.
The manufacturer's intended purpose, product characteristics and marketing claims are relevant to the legal classification.
Similarly, foreign registration or approval does not automatically replace the applicable Russian or EAEU registration requirements.
12. Regulatory Exceptions for Unregistered IVD Medical Devices
Article 38(11.1) of Federal Law No. 323-FZ establishes a limited mechanism for certain unregistered IVD medical devices.
Government Resolution No. 2026 of 24 November 2021 establishes the relevant requirements and authorisation procedure.
However, this exception is not a general exemption for commercial self-testing products.
It concerns IVD devices manufactured within a medical organisation and used within that same organisation under the specified conditions and with the required authorisation.
Consequently, a commercial manufacturer cannot use this special procedure as a substitute for ordinary registration of home testing kits.
Consultant Plus+2
13. Regulatory Challenges and Emerging Legal Issues
Several developing issues require attention in Russian biotechnology regulation.
1. False-positive and false-negative results
Incorrect diagnostic results can cause unnecessary treatment, delayed diagnosis or psychological harm. Regulatory assessment must therefore consider analytical and clinical performance.
2. Artificial intelligence-based testing
Some home diagnostic devices use AI-powered applications to interpret biological results. This creates questions concerning software qualification, validation, transparency and responsibility for incorrect interpretations.
3. Cross-border genetic testing
Foreign companies may receive biological samples or genetic information collected in Russia. Such activities can raise questions concerning consent, personal-data protection, international transfers and medical-device regulation.
4. Direct-to-consumer biotechnology
The increasing availability of genetic and fertility testing creates difficulties in distinguishing medical diagnosis from lifestyle and informational services.
5. Consumer misunderstanding
A self-testing kit may be technically compliant but still create risks if consumers misunderstand its limitations or interpret preliminary results as definitive diagnoses.
6. Regulatory surveillance
Roszdravnadzor monitors the circulation and safety of medical devices. Government Resolution No. 1829 of 19 November 2025 introduced amendments to the federal medical-device supervision framework, effective from 28 November 2025.
imdrf.org+1
14. Critical Legal Analysis
Russian self-testing regulation reflects the relationship between three important legal interests.
First, public health protection requires diagnostic products to demonstrate appropriate safety and performance.
Second, consumer autonomy requires individuals to have access to understandable and reliable diagnostic information.
Third, biological privacy requires protection of sensitive personal and genetic information generated through home testing.
A significant regulatory difficulty arises because self-testing transfers part of the diagnostic process from professional healthcare institutions to individual consumers.
Traditional laboratory regulation focuses heavily on laboratory competence and professional procedures. Self-testing requires additional attention to the capabilities of ordinary users, including sample collection, procedural errors and interpretation of results.
GOST R ISO 18113-5-2024 provides an important technical framework for addressing these issues. Nevertheless, the legal obligations concerning registration and market circulation arise primarily from the applicable legislation, rather than from the standard alone.
The effectiveness of the Russian regulatory system therefore depends on combining pre-market assessment, appropriate instructions, post-market monitoring and consumer protection.
15. Conclusion
Biotechnology self-testing kit regulation in Russia is based principally on Federal Law No. 323-FZ, Government Resolution No. 1416, EAEU Council Decision No. 46 of 2016 and relevant national standards.
Roszdravnadzor plays a central role in registration, supervision and medical-device safety monitoring.
Russian judicial practice demonstrates that:
Medical-device registration must correspond to the actual intended purpose.
Manufacturers cannot arbitrarily expand approved diagnostic functions.
Distributors must verify registration and product conformity.
Registration documentation is important in public procurement and commercial disputes.
Unregistered medical-device circulation can attract administrative or, in appropriate circumstances, criminal liability.
The central legal principle is that a self-testing kit must be demonstrated to be suitable for its intended diagnostic purpose, appropriately registered where required, and accompanied by sufficient information to permit safe use by non-professional consumers.
16. Important Legal References and Research Sources
| Legal authority | Subject |
|---|---|
| Federal Law No. 323-FZ, Article 38 | Medical-device regulation |
| Government Resolution No. 1416 (2012) | National medical-device registration |
| EAEU Decision No. 46 (2016) | EAEU registration and examination |
| Government Resolution No. 2026 (2021) | Special authorisation for certain unregistered IVD devices |
| Federal Law No. 152-FZ (2006) | Personal-data protection |
| Federal Law No. 2300-1 (1992) | Consumer protection |
| GOST R ISO 18113-1-2024 | General IVD labelling |
| GOST R ISO 18113-5-2024 | Self-testing equipment labelling |
| Russian Code of Administrative Offences, Article 6.33 | Medical-product circulation offences |
| Russian Criminal Code, Articles 238 and 238.1 | Product safety and medical-device offences |
Useful primary research sources:
Article 38 of Federal Law No. 323-FZ.
Roszdravnadzor – Medical Device Registration.
EAEU Council Decision No. 46 of 2016.
GOST R ISO 18113-5-2024 – Self-testing labelling standard.
Research note: The cited judgments are relevant medical-device precedents, not all direct decisions about consumer self-testing kits. The distinction is important when using them in academic writing or legal submissions.

comments